| LLYELI LILLY & Co | 47,840 | $44.0M |
| JNJJOHNSON & JOHNSON | 174,333 | $42.6M |
| ABBVAbbVie Inc. | 93,241 | $20.3M |
| MRKMerck & Co., Inc. | 105,561 | $12.7M |
| ABTABBOTT LABORATORIES | 121,979 | $12.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 46,057 | $12.5M |
| NVONovo Nordisk A/S | 315,270 | $11.6M |
| AZNASTRAZENECA PLC | 55,430 | $10.9M |
| GILDGILEAD SCIENCES, INC. | 72,977 | $10.2M |
| AMGNAMGEN INC | 27,649 | $9.7M |
| PMPhilip Morris International Inc | 37,780 | $6.2M |
| MCKMcKesson Corporation | 6,909 | $6.0M |
| NVSNovartis AG | 28,041 | $4.3M |
| TEVATeva Pharmaceutical Industries Limited | 134,465 | $4.1M |
| CORCencora Inc. | 12,614 | $4.0M |
| MRNAModerna, Inc. | 77,622 | $3.9M |
| CAHCardinal Health Inc. | 18,322 | $3.9M |
| REGNREGENERON PHARMACEUTICALS, INC. | 4,667 | $3.6M |
| PFEPFIZER INC | 112,033 | $3.1M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 54,774 | $3.0M |
| GMOptec International, Inc. | 36,644 | $2.7M |
| ZTSZoetis Inc. | 19,759 | $2.3M |
| BMYBRISTOL MYERS SQUIBB CO | 37,554 | $2.3M |
| PAHCPHIBRO ANIMAL HEALTH CORP | 28,634 | $1.6M |
| PBYIPUMA BIOTECHNOLOGY, INC. | 173,051 | $1.1M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2,360 | $1.1M |
| PLXProtalix BioTherapeutics, Inc. | 418,570 | $908K |
| TGTXTG THERAPEUTICS, INC. | 20,998 | $698K |
| DVADaVita Inc. | 3,149 | $484K |
| GEHCGE HealthCare Technologies Inc. | 6,362 | $454K |
| ELVElevance Health Inc. | 1,405 | $413K |
| IQVIQVIA Holdings Inc. | 2,254 | $384K |
| SRPTSarepta Therapeutics, Inc. | 17,492 | $381K |
| SNYSanofi | 7,122 | $343K |
| UTHRUNITED THERAPEUTICS Corp | 567 | $336K |
| IONSIONIS PHARMACEUTICALS INC | 4,341 | $326K |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 1,809 | $312K |
| VKTXViking Therapeutics, Inc. | 9,275 | $302K |
| BIIBBIOGEN INC. | 1,610 | $295K |
| CRSPCRISPR Therapeutics AG | 4,799 | $228K |
| CINGCingulate Inc. | 21,800 | $135K |
| ABOSAcumen Pharmaceuticals, Inc. | 50,000 | $118K |
| RXRXRECURSION PHARMACEUTICALS, INC. | 12,117 | $37K |
| HRTXHERON THERAPEUTICS, INC. /DE/ | 40,565 | $32K |
| GTBPGT Biopharma, Inc. | 11,996 | $5K |